Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy. - Wikidata - awgldk - TriplyDB

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

http://www.wikidata.org/entity/Q38256244

about

Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy Targeting Insulin Receptor with a Novel Internalizing Aptamer Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors In Vivo Bio-distribution and Efficient Tumor Targeting of Gelatin/Silica Nanoparticles for Gene Delivery.Nanoscaled aptasensors for multi-analyte sensing.Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX.Oligonucleotide therapeutics: chemistry, delivery and clinical progress.Modular Assembly of Cell-targeting Devices Based on an Uncommon G-quadruplex Aptamer.Aptamer selection and applications for breast cancer diagnostics and therapy.A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer.The application of aptamer 5TR1 in triple negative breast cancer target therapy.RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications.Aptamer Therapeutics in Cancer: Current and Future.Aptamers: novelty tools for cancer biology.Construction of self-powered cytosensing device based on ZnO nanodisks@g-CN quantum dots and application in the detection of CCRF-CEM cells

P2860

Q26782485-E5D83DD4-C5B2-4859-BD7D-5335D485168A Q28080168-288AC7E3-DB08-4811-8E29-9E1DE230817E Q28822291-99D5F381-9ADF-459D-8A0F-785444D7BC02 Q33832781-07D1D9E1-95AA-4BF8-B3F0-A0CBB07D9E5E Q35868868-4F8DA876-75E0-4B7E-90F2-EC7159BD86B2 Q36792407-6C069530-5F35-4078-A9E5-F4AB86E0CE26 Q38351737-87D87F54-7747-4593-A47F-890C93A1DF85 Q38609277-F636D8C3-268B-43D5-84A7-E647F685197F Q38618638-F8E76D4A-AED8-431B-AB4C-9AD0EBAD29AE Q38968703-B1D82C33-79D3-4725-A843-BB2E0F4CB297 Q47097941-89237F2F-381E-46AD-A7C9-A463E06116B1 Q47121338-FC34253C-42B3-4356-9561-7924A8B0A95E Q48187126-141B0676-1E7E-41EF-97C6-14ABEA1A95E9 Q50144632-4EA85E3A-D00E-41C6-9F70-915A58CD2DF3 Q52347485-0B355CA4-04CE-4E8A-8607-1AC423319E66 Q55285633-1224F57A-B336-4323-ACB6-CEFA50211625 Q57146969-9EE561E8-57A7-41FE-B2F2-79151ED031D2

P2860

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

http://www.wikidata.org/entity/Q38256244

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

@en

type

label

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

@en

prefLabel

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

@en

P1433

Q38256244-D31E8A85-5DA4-4CED-BF8A-B25B048B2380

P1476

Q38256244-9A3D351C-12A6-415C-AF7E-0414E0488DD2

P2093

Q38256244-296165CA-AE96-4824-8613-68A3B151B314

Q38256244-616F230C-15D3-46F5-A959-7BA06688A8FB

Q38256244-BE36CB35-3A71-46D1-BA09-B9396C0D24FD

Q38256244-E0D65AC9-5BFB-4ED6-9E58-3E1BBB345CFA

Q38256244-F02BC57A-929C-4579-84CA-7F70FEF4FAE1

P2860

Q38256244-07CD5680-D046-478C-9BD9-151CA2B721D9

Q38256244-0D08AE29-9FF0-46AA-B448-8FB04E78646D

Q38256244-0EFD2A35-0967-44F5-813D-5F4759430AB3

Q38256244-0F1BE726-E1D9-49F9-B3EA-D81073003CAC

Q38256244-120592A6-8A82-48EF-946C-EE15F3EFD291

Q38256244-14AFF3A7-BD5A-4A96-8149-6C4E98B03827

Q38256244-1857C2BC-06ED-474B-A00D-D0E6CDD9422B

Q38256244-1A2679FA-173A-4E17-92EF-940C32C11CA5

Q38256244-1B002E34-1B01-4FCE-A591-A56588E1FAFF

Q38256244-1B95C831-AB3D-470D-9B23-0A2B7D0EFBA0

P304

Q38256244-0384106A-6822-433C-8073-EC648F762089

P31

Q38256244-3B764A34-B92C-4F25-A5F9-98BC78B47255

Q38256244-8d66fa6e-a16e-455a-ac05-3ae5f952731d

P356

Q38256244-2E835D96-F110-420B-8DB6-743390E687B7

P433

Q38256244-586A0257-8F6F-47D7-B6F0-DCF69B9D0B6A

P478

Q38256244-F1B36184-507D-4637-9C67-1380944B80A5

P577

Q38256244-734D9363-3370-476D-AC71-37D81AE11E3C

P5875

Q38256244-BD37A1E1-253E-48C3-80D3-F3BBB668036E

P698

Q38256244-015BA4F7-D6D2-4EA7-989F-B583B001EC9F

P921

Q38256244-CA63FB1A-D374-4BDF-A596-78F8AAC9E720

P356

P1433

P1476

Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.

@en

P2093

Huijie Zhu

http://www.w3.org/2001/XMLSchema#string

Jin Li

http://www.w3.org/2001/XMLSchema#string

Mao Ye

http://www.w3.org/2001/XMLSchema#string

Weihong Tan

http://www.w3.org/2001/XMLSchema#string

Xiao-Bing Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

Nucleic acid aptamers: an emerging frontier in cancer therapy

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

In vitro selection of RNA molecules that bind specific ligands

Adaptive recognition by nucleic acid aptamers.

Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling.

Pharmacokinetics of combined doxorubicin and paclitaxel in mice.

Peptide aptamers: recent developments for cancer therapy.

SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

Alternative non-antibody scaffolds for molecular recognition.

P304

39-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201402312

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266378651

http://www.w3.org/2001/XMLSchema#string

P698

25277749

http://www.w3.org/2001/XMLSchema#string

P921